Floyd Herman, MD
Plastic Surgery · Lansdale, PANPI 1730416553
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sientra, Inc. accounts for 60.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2020 at $6,953 and has fallen 89.6% since, to $720 in 2025.
Across 121 payments — averaging $90.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$7K
- Axogen$1K
- Smith+Nephew$1K
- Organogenesis Inc.$606
- Mimedx Group, Inc.$405
- Reddress USA, Inc.$127
- plus $771 from 18 others
What the payments were for
- Consulting fees$6,52860%
- Travel & lodging$7097%
- Food & beverage$3,67134%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 3 | $6,546 |
| Axogen | 3 | $1,396 |
| Smith+Nephew | 44 | $1,057 |
| Organogenesis Inc. | 22 | $606 |
| Mimedx Group, Inc. | 12 | $405 |
| Reddress USA, Inc. | 1 | $127 |
| Hartmann USA, Inc. | 2 | $120 |
| Aroa Biosurgery Incorporated | 10 | $99 |
| Kerecis Limited | 1 | $91 |
| TELA Bio, Inc. | 2 | $76 |
| Bioventus LLC | 2 | $62 |
| KCI USA, Inc. | 2 | $48 |
| Solventum Corporation | 2 | $43 |
| Misonix Inc | 2 | $34 |
| Integra Lifesciences Corporation | 2 | $33 |
| Endo Pharmaceuticals Inc. | 2 | $29 |
| Next Science LLC | 1 | $28 |
| Motiva USA, LLC | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Lifenet Health | 2 | $18 |
| Urgo Medical North America, LLC | 1 | $17 |
| OVIK Health, LLC | 1 | $15 |
| Acell, Inc. | 1 | $10 |
| Cashflow Solutions, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,908 in reported general payments places this provider in the 80th percentile of 196 plastic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 48 | $358 |
| Cephalexin | 20 | $129 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $80 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Lansdale
- John FischerPhiladelphia$3.3M
- Suhail KanchwalaPhiladelphia$1.4M
- Stephen KovachPhiladelphia$825K
- Ivona PercecPhiladelphia$534K
- Evan KatzelPhiladelphia$338K
- Paul GlatPhiladelphia$325K
- Shaun MendenhallPhiladelphia$173K
- William ScarlettBensalem$133K
- Andrea MoreiraPittsburgh$133K
- Dominic BrandyPittsburgh$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.